W. Gregory
About
In The Last Decade
W. Gregory
37 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 1.4k
- General Health Professions 786
- Public Health, Environmental and Occupational Health 749
- Molecular Biology 734
- Pulmonary and Respiratory Medicine 468
Countries citing papers authored by W. Gregory
This map shows the geographic impact of W. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Gregory more than expected).
Fields of papers citing papers by W. Gregory
This network shows the impact of papers produced by W. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Gregory. The network helps show where W. Gregory may publish in the future.
Co-authorship network of co-authors of W. Gregory
This figure shows the co-authorship network connecting the top 25 collaborators of W. Gregory. A scholar is included among the top collaborators of W. Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Gregory. W. Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC) | 21 |
| 3 | A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer | 3 |
| 4 | 16 | |
| 5 | 9 | |
| 6 | 19 | |
| 7 | Mental health of hospital consultants: the effects of stress and satisfaction at work breakdown → | 763 |
| 8 | 67 | |
| 9 | 102 | |
| 10 | 72 | |
| 11 | 6 | |
| 12 | 252 | |
| 13 | 3 | |
| 14 | 142 | |
| 15 | Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. breakdown → | 555 |
| 16 | 101 | |
| 17 | 392 | |
| 18 | 152 | |
| 19 | 9 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.